In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mountain Province Diamonds Inc.

Latest From Mountain Province Diamonds Inc.

Dainippon, SanBio Call Time On Stroke Cell Therapy Alliance

Japanese companies agree to discontinue regenerative cell therapy pact after high-profile Phase II failure, but SanBio will move ahead with development and Dainippon will hold onto ex-partner stake for now.

Business Strategies Japan

Warning Letter Roundup & Recap

SmartMonitor battery pack troubles dog Philips Children’s Medical Ventures; maker of GenStrip glucose test strips cited for QS and MDR reg violations; the Portable Exchange Deionization System was labeled to meet the requirements of an outdated ANSI/AAMI standard. Nine quality-related warning letters were listed by FDA from Aug. 12 through Sept. 11.

Medical Device Compliance

How Drugs Are Distributed In Japan: Insider Analysis From International Alliances Ltd.’s Reed Maurer

A closer look at components of Japan’s distribution system reveals a vastly improved network than previous years.

BioPharmaceutical Japan

Pfizer And Mylan Team Up For Generics Opportunity In Japan

As the Japanese government tries to boost generics utilization, Pfizer and Mylan plan to leverage combined strengths to become a market leader by 2015.

BioPharmaceutical Japan
See All

Company Information

  • Industry
  • Medical Devices